Aducanumab Opinion
Journal Title: International Journal Of Medical Science And Clinical Research Studies - Year 2022, Vol 2, Issue 08
Abstract
Aducanumab (brand name Aduhelm) is the first FDA-approved, pharmacologic treatment for Alzheimer’s disease (AD)but many uncertainties remain regarding both efficacy and safety. Of paramount concern areassociated adverse effects including cerebral edema and hemorrhage which prompted a post-approval study. Aside from safety concerns, withdrawal from the market may occur if it fails to demonstrate efficacy as described in pre-approval reports
Authors and Affiliations
Asia Filatov, MD,Jonathan T. Grossman DO
Keywords
Related Articles
- EP ID EP733075
- DOI 10.47191/ijmscrs/v2-i8-12
- Views 36
- Downloads 0
Prevalence and Angulation of Mandibular Third Molar Impaction in Zliten, Libya: A Retrospective Radiographic Study
Objectives: This retrospective study investigates the prevalence and angulation of impacted mandibular third molars and the most affected sex in a sample of Libyan patients between the ages of (19 and 84) who live in Zli...
Impetigo: Diagnosis and Treatment at the First Level of Care
Bacterial skin infections are processes that are produced by the direct or indirect presence of different bacteria, whichcan infect the skin and/or its annexes. Knowledge of these processes is relevant becau...
Gunja (Abrus Precatorius): A Review
Gunja (Abrus precatorius Linn.), also known as Indian liquorice, is regarded as one of the mosttoxic but also visually stunning seeds in the world. It is classified as an Upavisha (semipoisonous medication...
Ultrasound Assessment of Acute Female Pelvic Pain of Ovarian Origin: Pictorial Essay and Brief Review
Ultrasound is the initial imaging modality in evaluating ovarian pathology in women in a fertile state, establishing the diagnosis in most cases and without exposing them to large doses of ionizing radiation. In this art...
A 5-year Retrospective Study of Burn Injury at Tarakan Regional General Hospital Jakarta
Introduction:Burn patients deserve more attention because of their high morbidity and mortality rates. According to the World Health Organization, approximately 180.000 deaths per year are associated with burn...